Abstract
3/2012
vol. 29
Review paper Status of combination drugs with betamethasone dipropionate and salicylic acid in the treatment of skin diseases
Postep Derm Alergol 2012; XXIX, 3: 196–204
[Polish version: Postep Derm Alergol 2012; XXIX, 3: 205–214]
[Polish version: Postep Derm Alergol 2012; XXIX, 3: 205–214]
Online publish date: 2012/07/27
Combinations of topical glucocorticoids (GCs) with other substances are very often used in dermatology. One of the most common combinations is betamethasone dipropionate and salicylic acid. Betamethasone dipropionate is a potent topical glucocorticoid (belonging to class III according to the European classification) which demonstrates anti-inflammatory, anti-proliferative, immunosuppressive and vasoconstrictive properties. Salicylic acid, in turn, has a strong keratolytic and slightly antiseptic action. The use of both components in one formulation provides a significantly better GC penetration through the skin, which is crucial for the treatment of hyperkeratotic lesions.
Keywords
betamethasone dipropionate, salicylic acid, mechanism of action, therapy
Integrated with